Wynford-Thomas D
Department of Pathology, University of Wales College of Medicine, Heath Park, Cardiff, United Kingdom.
Oncol Res. 1996;8(10-11):387-98.
The ability of mammalian cells to respond to extrinsic mitogens is downregulated in response to proliferative aging (senescence), and it is now likely that at least a subset of such lifespan checkpoints is triggered by a biological "clock" based on erosion of chromosome telomeres. This review outlines the intrinsic inhibitory signal pathways that link this clock to cell cycle arrest, focussing on the role of tumour suppressor gene products, particularly the p53 and pRb proteins. Emphasis is placed on cell-type specific differences in the timing of lifespan checkpoints, and the "choice" of the underlying inhibitory signal pathway. It is argued that such diversity may explain many differences between cell types in the selection of tumour suppressor gene mutations, providing for example a novel explanation for the difference in molecular pathology and clinical behaviour between two important subsets of human breast cancer.
哺乳动物细胞对外源性有丝分裂原作出反应的能力在增殖性衰老(细胞衰老)过程中会下调,现在很可能至少有一部分这样的寿命检查点是由基于染色体端粒侵蚀的生物“时钟”触发的。本综述概述了将这个时钟与细胞周期停滞联系起来的内在抑制信号通路,重点关注肿瘤抑制基因产物的作用,特别是p53和pRb蛋白。重点在于寿命检查点时间上的细胞类型特异性差异,以及潜在抑制信号通路的“选择”。有人认为,这种多样性可能解释了细胞类型在肿瘤抑制基因突变选择上的许多差异,例如为人类乳腺癌两个重要亚组之间分子病理学和临床行为的差异提供了一种新的解释。